Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 125, Issue 2, Pages 727-738Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI79651
Keywords
-
Categories
Funding
- NIH [EY019312, EY021126, EY18826, HG006790, HG006346, GM076430-09, 5T32EY013360-15, EY002687]
- Foundation Fighting Blindness
- Human Frontier Science Program
- Research to Prevent Blindness
Ask authors/readers for more resources
Mutations in the cellular retinaldehyde-binding protein (CRALBP, encoded by RLBP1) can lead to severe cone photoreceptor-mediated vision loss in patients. It is not known how CRALBP supports cone function or how altered CRALBP leads to cone dysfunction. Here, we determined that deletion of Rlbp1 in mice impairs the retinal visual cycle. Mice lacking CRALBP exhibited M-opsin mislocalization, M-cone loss, and impaired cone-driven visual behavior and light responses. Additionally, M-cone dark adaptation was largely suppressed in CRALBP-deficient animals. While rearing CRALBP-deficient mice in the dark prevented the deterioration of cone function, it did not rescue cone dark adaptation. Adeno-associated virus-mediated restoration of CRALBP expression specifically in Muller cells, but not retinal pigment epithelial (RPE) cells, rescued the retinal visual cycle and M-cone sensitivity in knockout mice. Our results identify Muller cell CRALBP as a key component of the retinal visual cycle and demonstrate that this pathway is important for maintaining normal cone-driven vision and accelerating cone dark adaptation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available